Cargando…
Clostridium difficile Infection in Special High-Risk Populations
Antibiotic use continues to be the most important risk factor for the development of Clostridium difficile infection (CDI) through disruption of the indigenous microbiota of the colon. This factor, together with environmental contamination, makes hospital and other healthcare facilities the perfect...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019980/ https://www.ncbi.nlm.nih.gov/pubmed/27515721 http://dx.doi.org/10.1007/s40121-016-0124-z |
_version_ | 1782453152381927424 |
---|---|
author | Cózar-Llistó, Alberto Ramos-Martinez, Antonio Cobo, Javier |
author_facet | Cózar-Llistó, Alberto Ramos-Martinez, Antonio Cobo, Javier |
author_sort | Cózar-Llistó, Alberto |
collection | PubMed |
description | Antibiotic use continues to be the most important risk factor for the development of Clostridium difficile infection (CDI) through disruption of the indigenous microbiota of the colon. This factor, together with environmental contamination, makes hospital and other healthcare facilities the perfect breeding ground for the infection. Several groups of patients are exposed to the hospital environment and, at the same time, affected by conditions that can make CDI more prevalent, more severe or make it present a different clinical picture. The list of such conditions appears too extensive to be reviewed in a single article. Nevertheless, several groups, including the critically ill, oncological patients, solid organ and hematopoietic transplant recipients, patients with inflammatory bowel disease, patients with kidney disease and pregnant women, have generated more attention and have been studied in more detail. On the other hand, pediatric patients constitute a controversial group because the large number of asymptomatic carriers makes interpretation of clinical findings and diagnostic tests difficult, as is the development of an appropriate approach to treatment. We present an in-depth discussion of CDI in these high-risk populations and we also review the issue of CDI in pediatric patients. |
format | Online Article Text |
id | pubmed-5019980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-50199802016-09-26 Clostridium difficile Infection in Special High-Risk Populations Cózar-Llistó, Alberto Ramos-Martinez, Antonio Cobo, Javier Infect Dis Ther Review Antibiotic use continues to be the most important risk factor for the development of Clostridium difficile infection (CDI) through disruption of the indigenous microbiota of the colon. This factor, together with environmental contamination, makes hospital and other healthcare facilities the perfect breeding ground for the infection. Several groups of patients are exposed to the hospital environment and, at the same time, affected by conditions that can make CDI more prevalent, more severe or make it present a different clinical picture. The list of such conditions appears too extensive to be reviewed in a single article. Nevertheless, several groups, including the critically ill, oncological patients, solid organ and hematopoietic transplant recipients, patients with inflammatory bowel disease, patients with kidney disease and pregnant women, have generated more attention and have been studied in more detail. On the other hand, pediatric patients constitute a controversial group because the large number of asymptomatic carriers makes interpretation of clinical findings and diagnostic tests difficult, as is the development of an appropriate approach to treatment. We present an in-depth discussion of CDI in these high-risk populations and we also review the issue of CDI in pediatric patients. Springer Healthcare 2016-08-11 2016-09 /pmc/articles/PMC5019980/ /pubmed/27515721 http://dx.doi.org/10.1007/s40121-016-0124-z Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Cózar-Llistó, Alberto Ramos-Martinez, Antonio Cobo, Javier Clostridium difficile Infection in Special High-Risk Populations |
title | Clostridium difficile Infection in Special High-Risk Populations |
title_full | Clostridium difficile Infection in Special High-Risk Populations |
title_fullStr | Clostridium difficile Infection in Special High-Risk Populations |
title_full_unstemmed | Clostridium difficile Infection in Special High-Risk Populations |
title_short | Clostridium difficile Infection in Special High-Risk Populations |
title_sort | clostridium difficile infection in special high-risk populations |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019980/ https://www.ncbi.nlm.nih.gov/pubmed/27515721 http://dx.doi.org/10.1007/s40121-016-0124-z |
work_keys_str_mv | AT cozarllistoalberto clostridiumdifficileinfectioninspecialhighriskpopulations AT ramosmartinezantonio clostridiumdifficileinfectioninspecialhighriskpopulations AT cobojavier clostridiumdifficileinfectioninspecialhighriskpopulations |